FR2293219B1 - - Google Patents

Info

Publication number
FR2293219B1
FR2293219B1 FR7536180A FR7536180A FR2293219B1 FR 2293219 B1 FR2293219 B1 FR 2293219B1 FR 7536180 A FR7536180 A FR 7536180A FR 7536180 A FR7536180 A FR 7536180A FR 2293219 B1 FR2293219 B1 FR 2293219B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7536180A
Other versions
FR2293219A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of FR2293219A1 publication Critical patent/FR2293219A1/fr
Application granted granted Critical
Publication of FR2293219B1 publication Critical patent/FR2293219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7536180A 1974-12-03 1975-11-26 Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques Granted FR2293219A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/529,180 US4020183A (en) 1974-12-03 1974-12-03 Nonionic surface active anti-herpes simplex viral agents

Publications (2)

Publication Number Publication Date
FR2293219A1 FR2293219A1 (fr) 1976-07-02
FR2293219B1 true FR2293219B1 (fr) 1979-09-21

Family

ID=24108844

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536180A Granted FR2293219A1 (fr) 1974-12-03 1975-11-26 Procede d'inactivation du virus de l'herpes banal par des agents tensio-actifs et non ioniques

Country Status (8)

Country Link
US (3) US4020183A (fr)
AU (1) AU504576B2 (fr)
BE (1) BE836192A (fr)
CA (1) CA1067826A (fr)
DE (1) DE2554428A1 (fr)
FR (1) FR2293219A1 (fr)
NL (1) NL7513985A (fr)
ZA (1) ZA757591B (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372977A (en) * 1977-05-31 1983-02-08 Block Drug Company, Inc. Polyoxethylene derivatives as antipruritic ectoparasiticide
US4199575A (en) * 1978-03-27 1980-04-22 Gunther Roland E Method of treating dermatitis venenata
US4657933A (en) * 1978-09-11 1987-04-14 Collins Harvey T Topical preparation and method for treating Herpes simplex virus infection
DE3001302A1 (de) * 1980-01-16 1981-07-23 Basf Ag, 6700 Ludwigshafen Verwendung von di-tert.-alkylphenolethoxylaten als loesungsvermittler fuer kosmetische und pharmazeutische praeparate
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
FR2507891A1 (fr) * 1981-06-18 1982-12-24 Gresval Laboratoires Medicament, notamment pour le traitement des maladies a virus du type herpes
CA1190148A (fr) * 1981-10-13 1985-07-09 Samuel S. Asculai Composes contenant de l'interferon
EP0077063B1 (fr) * 1981-10-13 1988-03-16 Exovir, Inc. Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4957734A (en) * 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
FR2528701B1 (fr) * 1982-06-16 1986-08-22 Sanofi Sa Compositions antiseborrheiques a usage cosmetique comportant au moins un alkylphenol polyoxyethylene
US4657934A (en) * 1982-08-23 1987-04-14 Collins Harvey T Method for treating Herpes simplex virus infection and topical preparation used therein
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
DE3625948A1 (de) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
IT1213453B (it) * 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
KR900015739A (ko) * 1989-04-24 1990-11-10 히비히 폰 모르쯔 비이온성 계면활성제를 함유하는 국소 치료용 항바이러스성 제약 조성물
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
ES2096592T3 (es) * 1989-08-09 1997-03-16 Osteotech Inc Proceso para la desinfeccion de tejido musculoesqueletico y tejidos asi preparados.
EP0466397A3 (en) * 1990-07-10 1992-05-06 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters
DE69219470T2 (de) * 1991-06-20 1997-11-06 Viro Tex Corp Topisches Präparat zur besseren Heilung von Herpesverletzungen
US5513662A (en) * 1991-12-31 1996-05-07 Osteotech, Inc. Preparation of bone for transplantation
DE4344697A1 (de) * 1993-12-27 1995-06-29 Beiersdorf Ag Corticosteroide enthaltende W/O-Lotion
US5556379A (en) * 1994-08-19 1996-09-17 Lifenet Research Foundation Process for cleaning large bone grafts and bone grafts produced thereby
US5977034A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Composition for cleaning bones
US5797871A (en) * 1994-08-19 1998-08-25 Lifenet Research Foundation Ultrasonic cleaning of allograft bone
US5976104A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Recirculation method for cleaning essentially intact bone grafts using pressure mediated flow of solutions and bone grafts produced thereby
DE4435288A1 (de) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen gegen Superinfektionen mit einem Gehalt an ethoxylierten und/oder propoxylierten Alkoholen und/oder Carbonsäuren
US6034073A (en) * 1995-04-24 2000-03-07 Novavax, Inc. Solvent detergent emulsions having antiviral activity
DE69618227T2 (de) * 1995-11-01 2002-08-14 Kimberly-Clark Worldwide, Inc. Mit antimikrobiellen zusammensetzungen getränkte tücher
US5700842A (en) * 1995-11-01 1997-12-23 Kimberly-Clark Worldwide, Inc. Methods of incorporating a hydrophobic substance into an aqueous solution
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US7229447B1 (en) 1998-08-25 2007-06-12 Advanced Photodynamics Technologies, Inc. Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant
US6455586B1 (en) * 1998-12-15 2002-09-24 Leonard L. Kaplan Topical immunomodulating compositions for treatment of aids, Hepatitis B & C, other infectious diseases, and cancer
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8232320B2 (en) * 1999-04-28 2012-07-31 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
WO2001062289A2 (fr) 2000-02-26 2001-08-30 Advanced Photodynamic Technologies, Inc. Eradication photodynamique d'organisme acellulaire et cellulaire, a l'aide d'un materiau photosensible et d'un tensioactif
US6699465B2 (en) 2001-05-18 2004-03-02 Albany Medical College Covalent attachment of polymer to cell to prevent virus bonding to receptor
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
EP1871349A1 (fr) * 2005-04-11 2008-01-02 Nanobio Corporation Halogenures d'ammonium quaternaires pour le traitement de pathologies infectieuses
CA2618974C (fr) * 2005-08-09 2014-01-28 Nanobio Corporation Compositions de nanoemulsions possedant une activite anti-inflammatoire
WO2008103416A1 (fr) * 2007-02-21 2008-08-28 Capps Charles L Amélioration synergique de propionate de calcium
EP2152304B1 (fr) 2007-05-02 2018-08-22 The Regents of the University of Michigan Compositions thérapeutiques à base de nanoémulsion et leurs procédés d'utilisation
US20090029179A1 (en) * 2007-05-14 2009-01-29 Fujifilm Corporation Two-liquid composition, hydrophilic composition and hydrophilic member
WO2010057197A1 (fr) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Compositions de vaccins contre le cancer et leurs méthodes d’utilisation
WO2010119966A1 (fr) * 2009-04-17 2010-10-21 シャボン玉石けん株式会社 Agent antiviral et produit nettoyant
US20110268761A1 (en) 2010-03-02 2011-11-03 Hapten Pharmaceuticals, Llc Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
WO2012090067A1 (fr) 2010-12-30 2012-07-05 Lfb Biotechnologies Glycols en tant qu'agents d'inactivation de pathogènes
FI128711B (en) 2017-03-17 2020-10-30 Jyri Nieminen Procedure for the treatment of herpes simplex symptoms on the skin and mucous membranes of mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2752284A (en) * 1952-09-27 1956-06-26 Ortho Pharma Corp Spermicidal composition
US2889250A (en) * 1955-12-29 1959-06-02 Ortho Pharma Corp Spermicidal alkylphenoxy-polyethoxyethanol emulsion
NL282265A (fr) * 1961-08-22

Also Published As

Publication number Publication date
FR2293219A1 (fr) 1976-07-02
AU8728075A (en) 1977-06-09
CA1067826A (fr) 1979-12-11
NL7513985A (nl) 1976-06-08
AU504576B2 (en) 1979-10-18
DE2554428C2 (fr) 1988-02-25
US4020183A (en) 1977-04-26
US4139630A (en) 1979-02-13
US4147803A (en) 1979-04-03
DE2554428A1 (de) 1976-06-10
ZA757591B (en) 1977-07-27
BE836192A (fr) 1976-06-02

Similar Documents

Publication Publication Date Title
FR2293219B1 (fr)
FR2261780A1 (fr)
HU168785B (fr)
FR2294489B1 (fr)
DK391375A (fr)
FR2294300B2 (fr)
AU495920B2 (fr)
JPS50101639U (fr)
FR2269336A1 (fr)
JPS50101123U (fr)
JPS50100738U (fr)
IN142732B (fr)
AU7099174A (fr)
AU7138274A (fr)
AU480209A (fr)
AU482332A (fr)
BG21353A1 (fr)
AU481457A (fr)
AU481580A (fr)
AU482019A (fr)
AU482110A (fr)
AU480469A (fr)
AU480580A (fr)
BG21632A1 (fr)
CH598006A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse